The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.
The compromise, which envisions spending $6.3 billion over the next decade, was condemned by consumer groups and some Democrats as a present to drugmakers that promised only paltry spending increases for underfunded federal programs.
But their objections were overwhelmed by an alliance among Republicans, many Democrats and the White House for a 996-page measure that bore wins for both parties. The Senate’s expected final approval next week would mark an uncommon episode of cooperation between the GOP-run 114th Congress – which plans to adjourn next week – and President Barack Obama in their dwindling days in office.
Click here to Read the full article : House Passes Controversial Medical Funding ‘Cures’ Bill
Share this entry
- American Health Council Welcomes Anikar Chhabra, MD, MS to Physician Board November 17, 2017
- The American Health Council Education Board Welcomes Carol Delville PhD, RN, ACNS-BC November 16, 2017
- American Health Council Elects Todd Heaton, MD, MPH to Board of Physicians November 15, 2017
- The American Health Council Welcomes Haley Love RN, OCN to Nursing Board November 14, 2017
- American Health Council Award Recipient Janet Backers, RN November 13, 2017
- American Health Council Appoints Amy Allard, BSN, MPH, RN to Board of Nurses November 13, 2017